ClinicalTrials.Veeva

Menu

In Vivo Clinical Trial of Porous Starch - Hydroxyapatite Composite Biomaterials for Bone Regeneration

C

Chiang Mai University

Status

Completed

Conditions

Open Fracture of Foot

Treatments

Device: bone void filler

Study type

Observational

Funder types

Other

Identifiers

NCT02910232
0425/58

Details and patient eligibility

About

Biodegradable scaffold is an accepted and commercialized medical alternative choice for bone regeneration. In this project we will used our new invention, porous starch- hydroxyapatite composite, for in vivo clinical trial.

Full description

The products were prepared from medical grade Thai rice starch mixed with high purity (>97%) hydroxyapatite powder from fresh cow bone, and already passed in vivo animal biocompatility test, then processed by freeze-drying. There were 44 volunteers from orthopedic and neurosurgical division, 4 and 40 patients, respectively.

Enrollment

44 patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • A patient who requires treatment by surgery and product implant in bone.
  • Not indicate sex type
  • 18-65 years
  • Patients accepted participate in the study.
  • Type of surgery will be treat for only bone.

Exclusion criteria

  • Refused to join the study.
  • Patients have an allergic history of carbohydrates and bovine bone.

Trial design

44 participants in 1 patient group

1
Description:
The groups were orthopedic patients and neurosurgical patients. The samples to fill the voiding space of bone and skull same as autografts.
Treatment:
Device: bone void filler

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems